BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Target Hit|| Long (1Y)
Morgan Stanley maintains equalweight on Ipca Laboratories
Expect gradual recovery of base business. Domestic markets will see a slowdown. Limited upside in US business due to regulatory issues. At current valuation stock looks fully priced.